Overview
Dr. Tanabe is the Laurel B. Chadwick Distinguished Professor in the Schools of Nursing and Medicine at Duke at the Duke University School of Nursing. Dr. Tanabe is a clinical and health services researcher. Her program of research focuses on improving systems of healthcare and patient outcomes for persons with sickle cell disease, a primarily minority and under-served population. Dr. Tanabe has received funding from the Agency for Health Care Research and Quality, the National Institute of Heart, Lung, and Blood, National Institute of Minority Health and Health Disparities and the National Institute of Nursing Research. Her work is advancing the care of individuals with sickle cell disease with a strong focus on improving pain management in the emergency department during a vaso-occlusive crisis. Her methodological expertise includes conducting multi-site clinical RCT’s, survey methods, qualitative research, quality improvement and implementation science. Dr. Tanabe has a strong passion for her work, individuals with sickle cell disease, and for mentoring students and faculty to conduct important, meaningful work to improve the health and well being of individuals and families.
Current Appointments & Affiliations
Laurel Chadwick Distinguished Professor of Nursing
·
2019 - Present
School of Nursing
Professor in the School of Nursing
·
2017 - Present
School of Nursing
Vice Dean, Research and Regulatory Affairs
·
2020 - Present
School of Nursing
Professor of Medicine
·
2017 - Present
Medicine, Hematology,
Medicine
Assistant Professor in Surgery
·
2017 - Present
Emergency Medicine,
Clinical Science Departments
Affiliate Faculty Member, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Initiatives & Academic Support Units
Recent Publications
Patient-reported pregnancy loss and maternal complications: Insights from the sickle cell disease implementation consortium.
Journal Article Int J Gynaecol Obstet · March 2025 OBJECTIVE: Sickle cell disease (SCD) is associated with complications during pregnancy and can negatively influence maternal outcomes. Our study aimed to determine the prevalence and predictors of maternal morbidity among participants enrolled in an eight- ... Full text Link to item CiteDevelopment of a Calculator to Determine Individualized Opioid Doses for Treatment of Vaso-Occlusive Episodes for Sickle Cell Disease in the Emergency Department.
Journal Article Jt Comm J Qual Patient Saf · January 2025 Sickle cell disease (SCD) is a life-limiting multisystem disease primarily affecting individuals of African and Latinx descent. Its most common complication is painful vaso-occlusive episodes (VOEs), which is also the most common reason individuals with SC ... Full text Link to item CiteEmergency department intravenous fluid resuscitation and renal outcomes among adults with sickle cell disease.
Journal Article American journal of hematology · January 2025 Full text CiteRecent Grants
Nurse LEADS: Training in Nurse-LEd models of care ADdressing the Social Determinants of Health
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Predictors of Pain Severity and Pain-Related Outcomes in Individuals with Sickle Cell Disease
ResearchAdvisor · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2028North Carolina Sickle Cell Data Collection
Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2024 - 2024View All Grants
Education, Training & Certifications
University of Illinois ·
1996
Ph.D.
Loyola University, Chicago ·
1990
M.S.N.
Rush University ·
1987
B.S.